Journals / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 5

Phenotypic spectrum of CHARGE syndrome based on clinical characteristics

Pages
911–915
Publication Date
2018-10-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: CHARGE syndrome should be considered as a differential diagnosis to detect the mild end of the spectrum, even if the patient does not fit the criteria.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: CHARGE syndrome is a rare autosomal dominant disease with multiple congenital anomalies and cognitive impairment, which is caused by mutations in the CHD7 gene.
📊
Key Findings & Data:All patients were tested for karyotype analysis and CHD7 gene mutation/deletion.
💡
Conclusion & Impact:Conclusion: CHARGE syndrome should be considered as a differential diagnosis to detect the mild end of the spectrum, even if the patient does not fit the criteria.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Choanal atresia · coloboma · CHD7 gene

Abstract

Background/aim: CHARGE syndrome is a rare autosomal dominant disease with multiple congenital anomalies and cognitive impairment, which is caused by mutations in the CHD7 gene. This study aimed to disclose the mild end of the phenotypic spectrum of CHARGE syndrome, which has a highly variable expressivity. Materials and methods: Twenty-one patients who had at least one of the major symptoms of CHARGE syndrome (coloboma, choanal atresia, characteristic ear anomalies, semicircular canal hypoplasia, and cranial nerve anomalies) were included in the study. All patients were tested for karyotype analysis and CHD7 gene mutation/deletion. Results: In the study population, 6 different mutations were detected in 5 patients, and 2 different polymorphisms were detected in the CHD7 gene in 3 patients. MLPA analysis of all coding exons of the CHD7 gene revealed no pathogenic deletion/duplication. Conclusion: CHARGE syndrome should be considered as a differential diagnosis to detect the mild end of the spectrum, even if the patient does not fit the criteria.

🔖

Cite This Article

KILIÇARSLAN, Ö. A., ATAMAN, E., GÜRSOY, S., HAZAN, F., RANDA, C., ÇANKAYA, T., ERÇAL, D., ÜLGENALP, A., BOZKAYA, Ö. G. (2018). Phenotypic spectrum of CHARGE syndrome based on clinical characteristics. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 5, 911–915. https://ajindex.com/articles/113486

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Sanlaville D, Verloes A. CHARGE syndrome: an update. Eur J Hum Genet 2007; 15: 389-399.
  2. Lalani SR, Hefner MA, Belmont JW, Davenport SLH. CHARGE syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, editors. GeneReviews [Internet]. Seattle, WA, USA: University of Washington, Seattle; 2012.
  3. Bergman JE, Janssen N, Hoefsloot LH, Jongmans MC, Hofstra RM, van Ravenswaaij-Arts CM. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. J Med Genet 2011; 48: 334-342.
  4. Husu E, Hove HD, Farholt S, Bille M, Tranebjærg L, Vogel I, Kreiborg S. Phenotype in 18 Danish subjects with genetically verified CHARGE syndrome. Clin Genet 2013; 83: 125-134.
  5. Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A 2010; 152A: 674-686.
  6. Blake KD, Prasad C. CHARGE syndrome. Orphanet J Rare Dis 2006; 1: 34. Abadie V, Wiener-Vacher S, Morisseau-Durand MP, Porée C, Amiel J, Amanou L, Peigné C, Lyonnet S, Manach Y. Vestibular anomalies in CHARGE syndrome: investigations on and consequences for postural development. Eur J Pediatr 2000; 159: 569-574.
  7. Green GE, Huq FS, Emery SB, Mukherji SK, Martin DM. CHD7 mutations and CHARGE syndrome in semicircular canal dysplasia. Otol Neurotol 2014; 35: 1466-1470.
  8. Ceruti S, Stinckens C, Cremers CW, Casselman JW. Temporal bone anomalies in the branchio-oto-renal syndrome: detailed computed tomographic and magnetic resonance imaging findings. Otol Neurotol 2002; 23: 200-207.
  9. Ming JE, Russell KL, Bason L, McDonald-McGinn DM, Zackai EH. Coloboma and other ophthalmologic anomalies in Kabuki syndrome: distinction from CHARGE association. Am J Med Genet 2003; 123A: 249-252.
  10. Igawa HH, Nishizawa N, Sugihara T, Inuyama Y. Inner ear abnormalities in Kabuki make-up syndrome: report of three cases. Am J Med Genet 2000; 92: 87-89.